TNF and steatosis: Beyond its impact on steatosis and fibrosis, trimetazidine also exerted a notable anti-inflammatory effect, resulting in a significant reduction in TNF-α levels compared with placebo, which is consistent with earlier clinical reports demonstrating anti-inflammatory effects in metabolic liver disease [19,23,24,25,26].